rdf:type |
|
lifeskim:mentions |
umls-concept:C0005495,
umls-concept:C0007134,
umls-concept:C0035143,
umls-concept:C0086661,
umls-concept:C0215848,
umls-concept:C0220781,
umls-concept:C0282636,
umls-concept:C0441655,
umls-concept:C0521451,
umls-concept:C1708843,
umls-concept:C1822686,
umls-concept:C2348110,
umls-concept:C2348977
|
pubmed:issue |
5
|
pubmed:dateCreated |
2007-5-7
|
pubmed:abstractText |
Many cancer cells are characterized by increased glycolysis and decreased respiration, even under aerobic conditions. The molecular mechanisms underlying this metabolic reprogramming are unclear. Here we show that hypoxia-inducible factor 1 (HIF-1) negatively regulates mitochondrial biogenesis and O(2) consumption in renal carcinoma cells lacking the von Hippel-Lindau tumor suppressor (VHL). HIF-1 mediates these effects by inhibiting C-MYC activity via two mechanisms. First, HIF-1 binds to and activates transcription of the MXI1 gene, which encodes a repressor of C-MYC transcriptional activity. Second, HIF-1 promotes MXI-1-independent, proteasome-dependent degradation of C-MYC. We demonstrate that transcription of the gene encoding the coactivator PGC-1beta is C-MYC dependent and that loss of PGC-1beta expression is a major factor contributing to reduced respiration in VHL-deficient renal carcinoma cells.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/HIF1A protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoxia-Inducible Factor 1, alpha...,
http://linkedlifedata.com/resource/pubmed/chemical/Oxygen,
http://linkedlifedata.com/resource/pubmed/chemical/PPARGC1B protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-myc,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/VHL protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Von Hippel-Lindau Tumor Suppressor...
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1535-6108
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
407-20
|
pubmed:dateRevised |
2007-12-3
|
pubmed:meshHeading |
pubmed-meshheading:17482131-Carcinoma, Renal Cell,
pubmed-meshheading:17482131-Carrier Proteins,
pubmed-meshheading:17482131-Cell Line, Tumor,
pubmed-meshheading:17482131-Humans,
pubmed-meshheading:17482131-Hypoxia-Inducible Factor 1, alpha Subunit,
pubmed-meshheading:17482131-Kidney Neoplasms,
pubmed-meshheading:17482131-Mitochondria,
pubmed-meshheading:17482131-Oxygen,
pubmed-meshheading:17482131-Proto-Oncogene Proteins c-myc,
pubmed-meshheading:17482131-RNA, Messenger,
pubmed-meshheading:17482131-Transcription, Genetic,
pubmed-meshheading:17482131-Von Hippel-Lindau Tumor Suppressor Protein
|
pubmed:year |
2007
|
pubmed:articleTitle |
HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity.
|
pubmed:affiliation |
Vascular Biology Program, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|